Anti-Human IL5 Recombinant Antibody (Reslizumab) (CAT#: TAB-136)
Recombinant monoclonal antibody to IL5. Reslizumab is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.
Host: Rat
Isotype: IgG4
Applications: Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
Specific Inquiry
RNA Expression
Figure 1 RNA cell line category: Cell line enhanced (Hep G2, TIME)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000113525-IL5
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000113525-IL5
Figure 1 RNA cell line category: Cell line enhanced (Hep G2, TIME)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000113525-IL5
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000113525-IL5
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Rat
- Derivation
- Humanized (from rat)
- Type
- IgG4
- Specificity
- Tested positive against native human antigen.
- Species Reactivity
- Human
- Applications
- Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
- Trade name
- cinquil
- CAS
- 241473-69-8
- Generic Name
- Reslizumab
- Related Disease
- Adult eosinophilic asthma
Product Property
- Purity
- >95.0% as determined by analysis by SDS-PAGE.
- Storage
- Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles.
Target
- Alternative Names
- Reslizumab;cinquil;241473-69-8;SCH 55700;SCH55700;CDP835;CEP-38072;hu39D10;IL5;interleukin 5 (colony-stimulating factor, eosinophil);interleukin-5;B cell differentiation factor I;EDF;eosinophil differentiation factor;IL 5;interleukin 5;T cell replacing fa
- Gene ID
- 3567
- UniProt ID
- P05113
Related Resources
Please refer to Reslizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Reslizumab.
Asthma
Inflammatory Bowel Diseases
Autoimmune Thyroid Disease
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Reslizumab"
Afuco™ Anti-IL5 ADCC Recombinant Antibody (Reslizumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL5. Reslizumab is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.
See other products for "IL5"
Humanized Antibody
| CAT | Product Name | Application | Type |
| TAB-031 | Anti-Human IL5 Recombinant Antibody (Mepolizumab) | IF, IP, Neut, FuncS, ELISA, FC, ICC | IgG1 - kappa |
Neutralizing Antibody
| CAT | Product Name | Application | Type |
| NEUT-1437CQ | Mouse Anti-IL5 Recombinant Antibody (clone CBL632) | ELISA, Neut | Mouse IgG2a |
| NEUT-1438CQ | Mouse Anti-IL5 Recombinant Antibody (clone CBL420) | Neut | Mouse IgG1 |
| NEUT-1439CQ | Rat Anti-IL5 Recombinant Antibody (clone CBL900) | ELISA, FC, IF, Neut, WB | Rat IgG1, κ |
| NEUT-1440CQ | Rat Anti-IL5 Recombinant Antibody (clone JES1-39D10) | ELISA, ELISPOT, Neut, ICFC, IHC, WB | Rat IgG2a, κ |
| NEUT-1441CQ | Rat Anti-IL5 Recombinant Antibody (clone JES1-5A10) | ELISA, ELISPOT, Neut | Rat IgG2a, κ |
Blocking Antibody
| CAT | Product Name | Application | Type |
| NEUT-1443CQ | Rat Anti-IL5 Recombinant Antibody (clone TRFK4) | ELISA, Inhib, WB | Rat IgG2a |
Recombinant Antibody
| CAT | Product Name | Application | Type |
| HPAB-0001-CN | Human Anti-IL5 Recombinant Antibody (clone h39D10) | ELISA | Humanized IgG |
| FAMAB-1406CQ | Human Anti-IL5 Recombinant Antibody (clone 2E3) | Neut, ELISA | Human IgG1 |
| FAMAB-1407CQ | Human Anti-IL5 Recombinant Antibody (clone 2F2) | Neut, ELISA | Human IgG1 |
| HPAB-1617WJ | Mouse Anti-IL5 Recombinant Antibody (clone 2F2) | ELISA, WB, Neut | Mouse IgG |
| HPAB-1618WJ | Mouse Anti-IL5 Recombinant Antibody (clone 2E3) | ELISA, WB, Neut | Mouse IgG |
scFv Fragment Antibody
| CAT | Product Name | Application | Type |
| HPAB-0001-CN-S(P) | Human Anti-IL5 Recombinant Antibody (clone h39D10); scFv Fragment | ELISA | Humanized scFv |
| HPAB-N0359-YC-S(P) | Human Anti-IL5 Recombinant Antibody; scFv Fragment (HPAB-N0359-YC-S(P)) | ELISA, Inhib | Human scFv |
| HPAB-0250CQ-S(P) | Human Anti-IL5 Recombinant Antibody; scFv Fragment (HPAB-0250CQ-S(P)) | ELISA, Neut, FuncS | Human scFv |
| HPAB-1617WJ-S(P) | Mouse Anti-IL5 Recombinant Antibody; scFv Fragment (clone 2F2) | ELISA, WB, Neut | Mouse scFv |
| HPAB-1618WJ-S(P) | Mouse Anti-IL5 Recombinant Antibody; scFv Fragment (clone 2E3) | ELISA, WB, Neut | Mouse scFv |
Fab Fragment Antibody
| CAT | Product Name | Application | Type |
| HPAB-0001-CN-F(E) | Human Anti-IL5 Recombinant Antibody (clone h39D10); Fab Fragment | ELISA | Humanized Fab |
| HPAB-N0359-YC-F(E) | Human Anti-IL5 Recombinant Antibody; Fab Fragment (HPAB-N0359-YC-F(E)) | ELISA, Inhib | Human Fab |
| HPAB-0250CQ-F(E) | Human Anti-IL5 Recombinant Antibody; Fab Fragment (HPAB-0250CQ-F(E)) | ELISA, Neut, FuncS | Human Fab |
| HPAB-0875-FY-S(P) | Human Anti-IL5 Recombinant Antibody; scFv Fragment (HPAB-0875-FY-S(P)) | ELISA | Humanized scFv |
| HPAB-1249-FY-S(P) | Mouse Anti-IL5 Recombinant Antibody; scFv Fragment (HPAB-1249-FY-S(P)) | Neut | Mouse scFv |
ADCC Enhanced Antibody
| CAT | Product Name | Application | Type |
| AFC-TAB-031 | Afuco™ Anti-IL5 ADCC Recombinant Antibody (Mepolizumab), ADCC Enhanced | IF, IP, Neut, FuncS, ELISA, FC | ADCC enhanced antibody |
| AFC-TAB-136 | Afuco™ Anti-IL5 ADCC Recombinant Antibody (Reslizumab), ADCC Enhanced | Neut, ELISA, IF, IP, FuncS, FC | ADCC enhanced antibody |
Customer Reviews and Q&As
Submit a review or a question
There are currently no Customer reviews or questions for TAB-136. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
* Abbreviations
AgonistAgonist
BABioassay
InhibInhibition
PGProteogenomics
StimStimulation
WBWestern Blot
Send Inquiry
© 2023 Creative BioLabs. All Rights Reserved